Get the Stockscreener App
11.40
0.97%
0.11
After Hours:
11.58
0.18
+1.58%
Fennec Pharmaceuticals Inc stock is traded at $11.40, with a volume of 218.90K.
It is up +0.97% in the last 24 hours and up +14.11% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$11.29
Open:
$11.29
24h Volume:
218.90K
Relative Volume:
0.93
Market Cap:
$399.77M
Revenue:
$51.00M
Net Income/Loss:
$-8.73M
P/E Ratio:
-38.49
EPS:
-0.2962
Net Cash Flow:
$-7.75M
1W Performance:
-3.63%
1M Performance:
+14.11%
6M Performance:
+27.95%
1Y Performance:
+31.64%
1-Day Range:
$10.88
$11.47
1-Week Range:
$10.88
$12.19
52-Week Range:
$5.65
$13.25
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
11.40 | 398.01M | 51.00M | -8.73M | -7.75M | -0.2962 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Initiated | B. Riley Securities | Buy |
| Jan-09-26 | Initiated | Piper Sandler | Overweight |
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
View All
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Fennec (FENC) Results Review: Reported EPS Tops Expectations in the Latest Reading; Share Response: The Share Price Sheds 4.63% at the CloseEPS Estimate Trend - vinanet.vn
Fennec (FENC) Technical Check: Adds 0.51% to Close at $11.89 at the Close; Current Setup: the Supplied Trading Band Runs From $11.30 to $12.48Throwback Trade - vinanet.vn
Jessica Vargas Appointed Vice President of Human Resources at Fennec Pharmaceuticals - hrtoday.in
(FENC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fennec Pharmaceuticals (FENC): Southpoint group files 13G/A showing 0% ownership - Stock Titan
Fennec Pharmaceuticals (FENC) Gets a Buy from Maxim Group - The Globe and Mail
Solas Capital Management (FENC) reports 1.89M Fennec shares, a 5.4% ownership stake - Stock Titan
Results: Fennec Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Moomoo
Results: Fennec Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views - Yahoo Finance
Fennec Pharmaceuticals Announces Q2 2026 Net Income and Revenue Growth - Kalkine Media
Fennec Pharmaceuticals (FENC) Stock Jumps As Profitability Raises A Bigger Question - webull.com
Fennec Pharmaceuticals (FENC) gains 9.6% stakeholder via Rosalind Advisors - Stock Titan
Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush - The Globe and Mail
Why Fennec Pharmaceuticals Inc stock plummeted yesterday - Wealth Awesome
What's Going On With Fennec Pharmaceuticals Inc Stock Thursday? - Wealth Awesome
B. Riley Financial Reaffirms "Buy" Rating for Adherex Technologies (NASDAQ:FENC) - MarketBeat
Wedbush Boosts Adherex Technologies (NASDAQ:FENC) Price Target to $16.00 - MarketBeat
Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade) - Seeking Alpha
Why Fennec Pharmaceuticals Inc stock surged yesterday - Wealth Awesome
B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating - marketscreener.com
Fennec Pharmaceuticals Inc FRX Earnings Beat Estimates by 248.5% - Wealth Awesome
Adherex Technologies Q2 2026 Earnings Call Transcript - MarketBeat
Fennec Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $16.17, Implies 48% Upside - TradingView
Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ... - Yahoo Finance
Fennec Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Adherex Technologies Q2 Earnings Call Highlights - newsbreak.com
Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat - marketscreener.com
Adherex Technologies (NASDAQ:FENC) Announces Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Fennec Pharmaceuticals surges 8% as Q2 earnings and revenue beat estimates - Yahoo Finance
Transcript : Fennec Pharmaceuticals Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
Fennec Pharmaceuticals Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Fennec Pharmaceuticals posts second quarter results and issues business update - tradersunion.com
Fennec Pharmaceuticals surges 8% on Q2 earnings, revenue beat By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals surges 8% on Q2 earnings, revenue beat - Investing.com
FENNEC PHARMACEUTICALS ($FENC) Releases Q2 2026 Earnings - Quiver Quantitative
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
FENC: Q2 2026 sales surged 78% year-over-year, with profitability and strong PEDMARKⓇ demand - TradingView
Fennec Pharmaceuticals Q2 sales rise on PEDMARK demand - TradingView
Biotech Stocks At 52-Week HighsHALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE - RTTNews
Will Fennec Pharmaceuticals Inc (FRX) Beat Estimates Again in Its Next Earnings Report? - Wealth Awesome
Fennec Pharmaceuticals' Market Cap Up US$70m Following Year Of Insider Stock Buying - Moomoo
Fennec Pharmaceuticals (TSE:FRX) Sets New 12-Month HighShould You Buy? - MarketBeat
Fennec Pharmaceuticals Inc. expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Responsive Playbooks and the FENC Inflection - Stock Traders Daily
Adherex Technologies (FENC) Projected to Release Quarterly Earnings on Thursday - MarketBeat
Fennec Pharmaceuticals Inc. - Menafn
Stocks in play: Fennec Pharmaceuticals Inc. - Yahoo! Finance Canada
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
FENC Q2'26 Earnings: EPS estimate is 0.02 USD - TradingView
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
3.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):